SO IF YOU LOOK AT THE WEIGHT REGAIN STATISTICS, AND YOU GO OUT LIKE A YEAR, DEPENDING ON THE STATS YOU USE AND THE INCLUSION CRITERIA FOR REGAIN, 50 TO 70% WILL REGAIN WHAT THEY LOST
Little TJ, Pilichiewicz AN, Russo A, Phillips L, Jones KL, Nauck MA, Wishart J, Horowitz M, Feinle-Bisset C: Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses
Misbranding a drug in interstate commerce is a prohibited act and can result in regulatory and/or legal enforcement actions, including the issuance of an untitled letter or warning letter, injunctions, or in extreme instances, criminal prosecution
That means considering factors such as: Individual health history and metabolic risk Treatment goals beyond the number on the scale Long-term adherence and lifestyle support Medication selection based on each person's unique needs Ongoing follow-up to adjust care as those needs change GLP-1based therapies have transformed obesity treatment for many patients, but they're only one part of a much larger picture
